-
Amin, J, Boyd, MA, Kumarasamy, N, Moore, CL, Losso, MH, Nwizu, CA, Mohapi, L, Kerr, SJ, Sohn, AH, Teppler, H, et al.
Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection.
PLOS ONE
10(10)
:
e0140623
2024
view publication
-
Moore, C, Hiscock, H, Lee, K.
Strengthening Care for Children (SC4C) : A Stepped-wedge Translational Trial to Reduce Hospital Burden - Statistical Analysis Plan.
2024
view publication
-
Moore, C.
BRACE Statistical Analysis Plan Addendum.
2024
view publication
-
Turkova, A, White, E, Kekitiinwa, AR, Mumbiro, V, Kaudha, E, Liberty, A, Ahimbisibwe, GM, Moloantoa, T, Srirompotong, U, Mosia, NR, et al.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
The Lancet Child & Adolescent Health
7(10)
:
718 -727
2023
view publication
-
Pittet, LF, Moore, CL, McDonald, E, Barry, S, Bonten, M, Campbell, J, Croda, J, Dalcolmo, M, Davidson, A, Douglas, MW, et al.
Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial.
EClinicalMedicine
64:
102203
2023
view publication